This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Le, T. Articles by Schimmer, B. P. Search for Related Content PubMed PubMed Citation Articles by Le, T. Articles by Schimmer, B. P.

The Regulation of MAPKs in Y1 Mouse Adrenocortical Tumor Cells

Banting and Best Department of Medical Research and Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada M5G 1L6

Address all correspondence and requests for reprints to: Bernard P. Schimmer, Ph.D., Professor, Banting and Best Department of Medical Research, University of Toronto, 112 College Street, Toronto, Ontario M5G 1L6, Canada. E-mail: bernard.schimmer{at}utoronto.ca

The regulation of the MAPKs, Erk₁ and Erk₂, and the MAPK kinase, Mek, were examined in the Y1 mouse adrenocortical tumor cell line and in the protein kinase A-defective mutant, Kin-8. ACTH and basic fibroblast growth factor each increased Mek phosphorylation and stimulated Mek activity in both cell lines and also activated the Erks at concentrations that paralleled their effects on Mek. The specific Mek inhibitor, PD98059, blocked the activation of the Erks by ACTH and basic fibroblast growth factor, indicating that Mek is the upstream activator of Erk. PD98059 did not block the phosphorylation of Mek, as might have been expected from previous studies; instead PD98059 inhibited the activity of the activated enzyme. In ACTH-stimulated, mutant Kin-8 cells, PD98059 paradoxically increased the amount of phosphorylated Mek, while preventing the activation of Erk. These results are interpreted as reflecting the loss of a protein kinase A-mediated inhibitory influence on Mek phosphorylation and activation.

This article has been cited by other articles:

				M. E. Janes, K. M. E. Chu, A. J. L. Clark, and P. J. King Mechanisms of Adrenocorticotropin-Induced Activation of Extracellularly Regulated Kinase 1/2 Mitogen-Activated Protein Kinase in the Human H295R Adrenal Cell Line Endocrinology, April 1, 2008; 149(4): 1898 - 1905. [Abstract] [Full Text] [PDF]

				M. Doufexis, H. L. Storr, P. J. King, and A. J. L. Clark Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus FASEB J, December 1, 2007; 21(14): 4095 - 4100. [Abstract] [Full Text] [PDF]

				P. R Manna, Y. Jo, and D. M Stocco Regulation of Leydig cell steroidogenesis by extracellular signal-regulated kinase 1/2: role of protein kinase A and protein kinase C signaling J. Endocrinol., April 1, 2007; 193(1): 53 - 63. [Abstract] [Full Text] [PDF]

				J. G Ferreira, C. D Cruz, D. Neves, and D. Pignatelli Increased extracellular signal regulated kinases phosphorylation in the adrenal gland in response to chronic ACTH treatment J. Endocrinol., March 1, 2007; 192(3): 647 - 658. [Abstract] [Full Text] [PDF]

				B. P. Schimmer, M. Cordova, H. Cheng, A. Tsao, A. B. Goryachev, A. D. Schimmer, and Q. Morris Global Profiles of Gene Expression Induced by Adrenocorticotropin in Y1 Mouse Adrenal Cells Endocrinology, May 1, 2006; 147(5): 2357 - 2367. [Abstract] [Full Text] [PDF]

				J. N. Winnay and G. D. Hammer Adrenocorticotropic Hormone-Mediated Signaling Cascades Coordinate a Cyclic Pattern of Steroidogenic Factor 1-Dependent Transcriptional Activation Mol. Endocrinol., January 1, 2006; 20(1): 147 - 166. [Abstract] [Full Text] [PDF]

				T. Hoang, I. S. Fenne, C. Cook, B. Borud, M. Bakke, E. A. Lien, and G. Mellgren cAMP-dependent Protein Kinase Regulates Ubiquitin-Proteasome-mediated Degradation and Subcellular Localization of the Nuclear Receptor Coactivator GRIP1 J. Biol. Chem., November 19, 2004; 279(47): 49120 - 49130. [Abstract] [Full Text] [PDF]

				M. Fassnacht, S. Hahner, I. A. Hansen, T. Kreutzberger, M. Zink, K. Adermann, F. Jakob, J. Troppmair, and B. Allolio N-Terminal Proopiomelanocortin Acts as a Mitogen in Adrenocortical Tumor Cells and Decreases Adrenal Steroidogenesis J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2171 - 2179. [Abstract] [Full Text] [PDF]

				P. Bey, A. B. Gorostizaga, P. M. Maloberti, R. C. Lozano, C. Poderoso, F. C. Maciel, E. J. Podesta, and C. Paz Adrenocorticotropin Induces Mitogen-Activated Protein Kinase Phosphatase 1 in Y1 Mouse Adrenocortical Tumor Cells Endocrinology, April 1, 2003; 144(4): 1399 - 1406. [Abstract] [Full Text] [PDF]

				M. Desclozeaux, I. N. Krylova, F. Horn, R. J. Fletterick, and H. A. Ingraham Phosphorylation and Intramolecular Stabilization of the Ligand Binding Domain in the Nuclear Receptor Steroidogenic Factor 1 Mol. Cell. Biol., October 15, 2002; 22(20): 7193 - 7203. [Abstract] [Full Text] [PDF]

				M. B. Sewer and M. R. Waterman Adrenocorticotropin/Cyclic Adenosine 3',5'-Monophosphate-Mediated Transcription of the Human CYP17 Gene in the Adrenal Cortex Is Dependent on Phosphatase Activity Endocrinology, May 1, 2002; 143(5): 1769 - 1777. [Abstract] [Full Text] [PDF]

				D. A. Dewi, D. R. E. Abayasekara, and C. P. D. Wheeler-Jones Requirement for ERK1/2 Activation in the Regulation of Progesterone Production in Human Granulosa-Lutein Cells Is Stimulus Specific Endocrinology, March 1, 2002; 143(3): 877 - 888. [Abstract] [Full Text] [PDF]